atropine has been researched along with reboxetine in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 626 | 193 | 184 |
Protein | Taxonomy | atropine (IC50) | reboxetine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conklin, D; Eisenach, JC; Obata, H | 1 |
1 other study(ies) available for atropine and reboxetine
Article | Year |
---|---|
Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity after surgery in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atropine; Behavior, Animal; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drosophila Proteins; Drug Interactions; Hyperalgesia; Idazoxan; Male; Morpholines; Muscarinic Antagonists; Pain Threshold; Pain, Postoperative; Peptides; Rats; Rats, Sprague-Dawley; Reboxetine; Snail Family Transcription Factors; Spinal Cord; Time Factors; Transcription Factors | 2005 |